12 Januaru 2016 - The EMA has released an overview of its 2015 key recommendations in relation to the marketing authorisations of new medicines and the safety monitoring of authorised medicines.

For more details, go to: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2016/01/news_detail_002454.jsp&mid=WC0b01ac058004d5c1